Particulate materials

Details for Australian Patent Application No. 2004237131 (hide)

Owner Nektar Therapeutics UK Ltd

Inventors Daintree, Linda Sharon; Walker, Stephen Ernest; German, Caroline Sophie

Agent Davies Collison Cave

Pub. Number AU-B-2004237131

PCT Pub. Number WO2004/098561

Priority 0310636.6 08.05.03 GB; 0329964.1 24.12.03 GB

Filing date 5 May 2004

Wipo publication date 18 November 2004

Acceptance publication date 10 September 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/196 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/098561 Priority application(s): WO2004/098561

10 September 2009 Application Accepted

  Published as AU-B-2004237131

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237132-Therapeutic agents comprising an antiangiogenic agent in combination with an Src-inhibitor and their therapeutic use

2004237130-Positive modulators of nicotinic acetylcholine receptors